{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:24:53Z","timestamp":1793910293691,"version":"4.8.0"},"reference-count":195,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s12035-024-04654-y","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T03:48:48Z","timestamp":1739764128000},"page":"7975-7997","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Unlocking the Neuroprotective Potential of Silymarin: A Promising Ally in Safeguarding the Brain from Alzheimer\u2019s Disease and Other Neurological Disorders"],"prefix":"10.1007","volume":"62","author":[{"given":"Abdulmajeed G.","family":"Almutary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Yasmin","family":"Begum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Siddiqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payal","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karan","family":"Wadhwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Govind","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danish","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopalakrishnan","family":"Padmapriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navin","family":"Kedia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajni","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aashna","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Dheepak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mosleh Mohammad","family":"Abomughaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9486-4069","authenticated-orcid":false,"given":"Niraj Kumar","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,17]]},"reference":[{"key":"4654_CR1","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/J.1582-4934.2010.01010.X","volume":"14","author":"KA Jellinger","year":"2010","unstructured":"Jellinger KA (2010) Basic mechanisms of neurodegeneration: a critical update. J Cell Mol Med 14:457\u2013487. https:\/\/doi.org\/10.1111\/J.1582-4934.2010.01010.X","journal-title":"J Cell Mol Med"},{"key":"4654_CR2","doi-asserted-by":"publisher","first-page":"12861","DOI":"10.1111\/acel.12861","volume":"18","author":"V Atella","year":"2019","unstructured":"Atella V, Piano Mortari A, Kopinska J et al (2019) Trends in age-related disease burden and healthcare utilization. Aging Cell 18:12861. https:\/\/doi.org\/10.1111\/acel.12861","journal-title":"Aging Cell"},{"key":"4654_CR3","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1242\/DMM.030205","volume":"10","author":"AD Gitler","year":"2017","unstructured":"Gitler AD, Dhillon P, Shorter J (2017) Neurodegenerative disease: models, mechanisms, and a new hope. Dis Model Mech 10:499. https:\/\/doi.org\/10.1242\/DMM.030205","journal-title":"Dis Model Mech"},{"key":"4654_CR4","doi-asserted-by":"publisher","first-page":"12495","DOI":"10.3390\/IJERPH191912495","volume":"30","author":"EA Ayeni","year":"2022","unstructured":"Ayeni EA, Aldossary AM, Ayejoto DA et al (2022) Neurodegenerative diseases: implications of environmental and climatic influences on neurotransmitters and neuronal hormones activities. Int J Environ Res Public Health 30:12495. https:\/\/doi.org\/10.3390\/IJERPH191912495","journal-title":"Int J Environ Res Public Health"},{"key":"4654_CR5","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"AJ Ferrari","year":"2024","unstructured":"Ferrari AJ, Santomauro DF, Aali A et al (2024) Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systema. Lancet 403:2133\u20132161. https:\/\/doi.org\/10.1016\/S0140-6736(24)00757-8","journal-title":"Lancet"},{"key":"4654_CR6","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","volume":"23","author":"JD Steinmetz","year":"2024","unstructured":"Steinmetz JD, Seeher KM, Schiess N et al (2024) Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol 23:344\u2013381. https:\/\/doi.org\/10.1016\/S1474-4422(24)00038-3","journal-title":"Lancet Neurol"},{"key":"4654_CR7","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/S0140-6736(24)00685-8","volume":"403","author":"SE Vollset","year":"2024","unstructured":"Vollset SE, Ababneh HS, Abate YH et al (2024) Burden of disease scenarios for 204 countries and territories, 2022\u20132050: a forecasting analysis for the Global Burden of Disease Study 2021. Lancet 403:2204\u20132256. https:\/\/doi.org\/10.1016\/S0140-6736(24)00685-8","journal-title":"Lancet"},{"key":"4654_CR8","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","volume":"186","author":"DM Wilson","year":"2023","unstructured":"Wilson DM, Cookson MR, Van Den Bosch L et al (2023) Hallmarks of neurodegenerative diseases. Cell 186:693\u2013714. https:\/\/doi.org\/10.1016\/j.cell.2022.12.032","journal-title":"Cell"},{"key":"4654_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1179\/1476830511Y.0000000028","volume":"15","author":"SL Albarracin","year":"2012","unstructured":"Albarracin SL, Stab B, Casas Z et al (2012) Effects of natural antioxidants in neurodegenerative disease. Nutr Neurosci 15:1\u20139. https:\/\/doi.org\/10.1179\/1476830511Y.0000000028","journal-title":"Nutr Neurosci"},{"key":"4654_CR10","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.3389\/FPSYG.2018.02061","volume":"9","author":"TL McIsaac","year":"2018","unstructured":"McIsaac TL, Fritz NE, Quinn L, Muratori LM (2018) Cognitive-motor interference in neurodegenerative disease: a narrative review and implications for clinical management. Front Psychol 9:2061. https:\/\/doi.org\/10.3389\/FPSYG.2018.02061","journal-title":"Front Psychol"},{"key":"4654_CR11","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.3390\/IJMS23031851","volume":"23","author":"RNL Lamptey","year":"2022","unstructured":"Lamptey RNL, Chaulagain B, Trivedi R et al (2022) A review of the common neurodegenerative disorders: current therapeutic approaches and the potential role of nanotherapeutics. Int J Mol Sci 23:1851. https:\/\/doi.org\/10.3390\/IJMS23031851","journal-title":"Int J Mol Sci"},{"key":"4654_CR12","doi-asserted-by":"publisher","first-page":"452270","DOI":"10.3389\/fphar.2019.01008","volume":"10","author":"L Guzman-Martinez","year":"2019","unstructured":"Guzman-Martinez L, Maccioni RB, Andrade V et al (2019) Neuroinflammation as a common feature of neurodegenerative disorders. Front Pharmacol 10:452270. https:\/\/doi.org\/10.3389\/fphar.2019.01008","journal-title":"Front Pharmacol"},{"issue":"27","key":"4654_CR13","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","volume":"276","author":"O Hansson","year":"2021","unstructured":"Hansson O (2021) (2021) Biomarkers for neurodegenerative diseases. Nat Med 276(27):954\u2013963. https:\/\/doi.org\/10.1038\/s41591-021-01382-x","journal-title":"Nat Med"},{"key":"4654_CR14","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.3390\/JCM9041061","volume":"9","author":"M Sharifi-Rad","year":"2020","unstructured":"Sharifi-Rad M, Lankatillake C, Dias DA et al (2020) Impact of natural compounds on neurodegenerative disorders: from preclinical to pharmacotherapeutics. J Clin Med 9:1061. https:\/\/doi.org\/10.3390\/JCM9041061","journal-title":"J Clin Med"},{"key":"4654_CR15","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/S0140-6736(24)00932-2","volume":"403","author":"M Zhou","year":"2024","unstructured":"Zhou M, Shen H (2024) Forecasting the global burden of disease to 2050. Lancet 403:1961\u20131963. https:\/\/doi.org\/10.1016\/S0140-6736(24)00932-2","journal-title":"Lancet"},{"key":"4654_CR16","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","volume":"7","author":"E Nichols","year":"2022","unstructured":"Nichols E, Steinmetz JD, Vollset SE et al (2022) Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Heal 7:e105\u2013e125. https:\/\/doi.org\/10.1016\/S2468-2667(21)00249-8","journal-title":"Lancet Public Heal"},{"key":"4654_CR17","doi-asserted-by":"publisher","first-page":"742408","DOI":"10.3389\/fnagi.2022.742408","volume":"14","author":"MB Abubakar","year":"2022","unstructured":"Abubakar MB, Sanusi KO, Ugusman A et al (2022) Alzheimer\u2019s disease: an update and insights into pathophysiology. Front Aging Neurosci 14:742408. https:\/\/doi.org\/10.3389\/fnagi.2022.742408","journal-title":"Front Aging Neurosci"},{"key":"4654_CR18","doi-asserted-by":"publisher","first-page":"469627","DOI":"10.3389\/FPHAR.2019.01108\/BIBTEX","volume":"10","author":"CG Theleritis","year":"2019","unstructured":"Theleritis CG, Siarkos KT, Politis AM (2019) Unmet needs in pharmacological treatment of apathy in Alzheimer\u2019s disease: a systematic review. Front Pharmacol 10:469627. https:\/\/doi.org\/10.3389\/FPHAR.2019.01108\/BIBTEX","journal-title":"Front Pharmacol"},{"key":"4654_CR19","doi-asserted-by":"publisher","first-page":"115522","DOI":"10.1016\/j.bcp.2023.115522","volume":"211","author":"AR Monteiro","year":"2023","unstructured":"Monteiro AR, Barbosa DJ, Remi\u00e3o F, Silva R (2023) Alzheimer\u2019s disease: insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs. Biochem Pharmacol 211:115522. https:\/\/doi.org\/10.1016\/j.bcp.2023.115522","journal-title":"Biochem Pharmacol"},{"key":"4654_CR20","doi-asserted-by":"publisher","first-page":"102289","DOI":"10.1016\/J.ARR.2024.102289","volume":"96","author":"A Akhtar","year":"2024","unstructured":"Akhtar A, Singh S, Kaushik R et al (2024) Types of memory, dementia, Alzheimer\u2019s disease, and their various pathological cascades as targets for potential pharmacological drugs. Ageing Res Rev 96:102289. https:\/\/doi.org\/10.1016\/J.ARR.2024.102289","journal-title":"Ageing Res Rev"},{"key":"4654_CR21","doi-asserted-by":"publisher","unstructured":"Ekundayo BE, Obafemi TO, Adewale OB et al (2024) Oxidative stress, endoplasmic reticulum stress and apoptosis in the pathology of Alzheimer\u2019s disease. Cell Biochem Biophys. https:\/\/doi.org\/10.1007\/S12013-024-01248-2","DOI":"10.1007\/S12013-024-01248-2"},{"key":"4654_CR22","doi-asserted-by":"publisher","unstructured":"Jain S, Goel D, Nazir SS, et al (2023) Pathophysiology and management approaches in Alzheimer\u2019s disease. In: Mishra A, Kulhari H (eds) Drug delivery strategies in neurological disorders: Challenges and opportunities. Springer Nature Singapore, pp 77\u2013102. https:\/\/doi.org\/10.1007\/978-981-99-6807-7_4","DOI":"10.1007\/978-981-99-6807-7_4"},{"key":"4654_CR23","doi-asserted-by":"publisher","first-page":"101078","DOI":"10.1016\/j.lanwpc.2024.101078","volume":"46","author":"T Xu","year":"2024","unstructured":"Xu T, Dong W, Liu J et al (2024) Disease burden of Parkinson\u2019s disease in China and its provinces from 1990 to 2021: findings from the global burden of disease study 2021. Lancet Reg Heal - West Pacific 46:101078. https:\/\/doi.org\/10.1016\/j.lanwpc.2024.101078","journal-title":"Lancet Reg Heal - West Pacific"},{"key":"4654_CR24","doi-asserted-by":"publisher","unstructured":"Emamzadeh FN, Surguchov A (2018) Parkinson\u2019s disease: biomarkers, treatment, and risk factors. Front Neurosci 12:. https:\/\/doi.org\/10.3389\/FNINS.2018.00612","DOI":"10.3389\/FNINS.2018.00612"},{"key":"4654_CR25","doi-asserted-by":"publisher","unstructured":"Xicoy H, Wieringa B, Martens GJM (2019) The role of lipids in Parkinson\u2019s disease. Cells 8:. https:\/\/doi.org\/10.3390\/CELLS8010027","DOI":"10.3390\/CELLS8010027"},{"key":"4654_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s42269-023-01047-4","volume":"47","author":"A Sayyaed","year":"2023","unstructured":"Sayyaed A, Saraswat N, Vyawahare N, Kulkarni A (2023) A detailed review of pathophysiology, epidemiology, cellular and molecular pathways involved in the development and prognosis of Parkinson\u2019s disease with insights into screening models. Bull Natl Res Cent 47:1\u201316. https:\/\/doi.org\/10.1186\/s42269-023-01047-4","journal-title":"Bull Natl Res Cent"},{"key":"4654_CR27","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","volume":"403","author":"HR Morris","year":"2024","unstructured":"Morris HR, Spillantini MG, Sue CM, Williams-Gray CH (2024) The pathogenesis of Parkinson\u2019s disease. Lancet 403:293\u2013304. https:\/\/doi.org\/10.1016\/S0140-6736(23)01478-2","journal-title":"Lancet"},{"key":"4654_CR28","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/JNNP-2019-322338","volume":"91","author":"J Jankovic","year":"2020","unstructured":"Jankovic J, Tan EK (2020) Parkinson\u2019s disease: etiopathogenesis and treatment. J Neurol Neurosurg Psychiatry 91:795\u2013808. https:\/\/doi.org\/10.1136\/JNNP-2019-322338","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4654_CR29","doi-asserted-by":"publisher","unstructured":"Ranjan S, Gautam A (2023) Pharmaceutical prospects of silymarin for the treatment of neurological patients: an updated insight. Front Neurosci 17:. https:\/\/doi.org\/10.3389\/FNINS.2023.1159806","DOI":"10.3389\/FNINS.2023.1159806"},{"key":"4654_CR30","doi-asserted-by":"publisher","first-page":"146741","DOI":"10.3389\/fmolb.2015.00054","volume":"2","author":"M Agrawal","year":"2015","unstructured":"Agrawal M, Biswas A (2015) Molecular diagnostics of neurodegenerative disorders. Front Mol Biosci 2:146741. https:\/\/doi.org\/10.3389\/fmolb.2015.00054","journal-title":"Front Mol Biosci"},{"key":"4654_CR31","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/J.MITO.2021.03.009","volume":"58","author":"S Singh","year":"2021","unstructured":"Singh S, Singh TG, Rehni AK et al (2021) Reviving mitochondrial bioenergetics: a relevant approach in epilepsy. Mitochondrion 58:213\u2013226. https:\/\/doi.org\/10.1016\/J.MITO.2021.03.009","journal-title":"Mitochondrion"},{"key":"4654_CR32","doi-asserted-by":"publisher","first-page":"918","DOI":"10.2174\/1570159X18666200207120949","volume":"18","author":"S Singh","year":"2020","unstructured":"Singh S, Singh TG (2020) Role of nuclear factor kappa B (NF-\u03baB) signalling in neurodegenerative diseases: an mechanistic approach. Curr Neuropharmacol 18:918\u2013935. https:\/\/doi.org\/10.2174\/1570159X18666200207120949","journal-title":"Curr Neuropharmacol"},{"key":"4654_CR33","doi-asserted-by":"publisher","first-page":"136020","DOI":"10.1016\/j.chemosphere.2022.136020","volume":"307","author":"F Islam","year":"2022","unstructured":"Islam F, Islam MM, Khan Meem AF et al (2022) Multifaceted role of polyphenols in the treatment and management of neurodegenerative diseases. Chemosphere 307:136020. https:\/\/doi.org\/10.1016\/j.chemosphere.2022.136020","journal-title":"Chemosphere"},{"key":"4654_CR34","doi-asserted-by":"publisher","first-page":"5100904","DOI":"10.1155\/2022\/5100904","volume":"2022","author":"F Islam","year":"2022","unstructured":"Islam F, Khadija JF, Harun-Or-Rashid M et al (2022) Bioactive compounds and their derivatives: an insight into prospective phytotherapeutic approach against Alzheimer\u2019s disease. Oxid Med Cell Longev 2022:5100904. https:\/\/doi.org\/10.1155\/2022\/5100904","journal-title":"Oxid Med Cell Longev"},{"key":"4654_CR35","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1007\/s12035-023-03706-z","volume":"61","author":"F Islam","year":"2024","unstructured":"Islam F, Roy S, Zehravi M et al (2024) Polyphenols targeting MAP kinase signaling pathway in neurological diseases: understanding molecular mechanisms and therapeutic targets. Mol Neurobiol 61:2686\u20132706. https:\/\/doi.org\/10.1007\/s12035-023-03706-z","journal-title":"Mol Neurobiol"},{"key":"4654_CR36","doi-asserted-by":"publisher","first-page":"766","DOI":"10.2174\/1871527320666211119122150","volume":"21","author":"RR Kumar","year":"2021","unstructured":"Kumar RR, Singh L, Thakur A et al (2021) Role of vitamins in neurodegenerative diseases: a review. CNS Neurol Disord - Drug Targets 21:766\u2013773. https:\/\/doi.org\/10.2174\/1871527320666211119122150","journal-title":"CNS Neurol Disord - Drug Targets"},{"key":"4654_CR37","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/J.JCONREL.2006.04.015","volume":"113","author":"DV Ratnam","year":"2006","unstructured":"Ratnam DV, Ankola DD, Bhardwaj V et al (2006) Role of antioxidants in prophylaxis and therapy: a pharmaceutical perspective. J Control Release 113:189\u2013207. https:\/\/doi.org\/10.1016\/J.JCONREL.2006.04.015","journal-title":"J Control Release"},{"key":"4654_CR38","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3390\/ANTIOX13040429","volume":"13","author":"M Rudrapal","year":"2024","unstructured":"Rudrapal M, Rakshit G, Singh RP et al (2024) Dietary polyphenols: review on chemistry\/sources, bioavailability\/metabolism, antioxidant effects, and their role in disease management. Antioxidants 13:429. https:\/\/doi.org\/10.3390\/ANTIOX13040429","journal-title":"Antioxidants"},{"key":"4654_CR39","doi-asserted-by":"publisher","first-page":"6403","DOI":"10.3390\/molecules28176403","volume":"28","author":"I Iqbal","year":"2023","unstructured":"Iqbal I, Wilairatana P, Saqib F et al (2023) Plant polyphenols and their potential benefits on cardiovascular health: a review. Molecules 28:6403. https:\/\/doi.org\/10.3390\/molecules28176403","journal-title":"Molecules"},{"key":"4654_CR40","doi-asserted-by":"publisher","first-page":"153320","DOI":"10.1016\/j.phymed.2020.153320","volume":"79","author":"R Haddadi","year":"2020","unstructured":"Haddadi R, Shahidi Z, Eyvari-Brooshghalan S (2020) Silymarin and neurodegenerative diseases: therapeutic potential and basic molecular mechanisms. Phytomedicine 79:153320. https:\/\/doi.org\/10.1016\/j.phymed.2020.153320","journal-title":"Phytomedicine"},{"key":"4654_CR41","doi-asserted-by":"publisher","unstructured":"Gillessen A, Schmidt HHJ (2020) Silymarin as supportive treatment in liver diseases: a narrative review. Adv Ther 37:. https:\/\/doi.org\/10.1007\/S12325-020-01251-Y","DOI":"10.1007\/S12325-020-01251-Y"},{"key":"4654_CR42","doi-asserted-by":"publisher","unstructured":"Camini FC, Costa DC (2020) Silymarin: not just another antioxidant. J Basic Clin Physiol Pharmacol 31:. https:\/\/doi.org\/10.1515\/JBCPP-2019-0206","DOI":"10.1515\/JBCPP-2019-0206"},{"key":"4654_CR43","doi-asserted-by":"publisher","first-page":"5327","DOI":"10.3390\/molecules27165327","volume":"27","author":"K Wadhwa","year":"2022","unstructured":"Wadhwa K, Pahwa R, Kumar M et al (2022) Mechanistic insights into the pharmacological significance of silymarin. Molecules 27:5327. https:\/\/doi.org\/10.3390\/molecules27165327","journal-title":"Molecules"},{"key":"4654_CR44","doi-asserted-by":"publisher","first-page":"361297","DOI":"10.3389\/FPHAR.2018.00422\/BIBTEX","volume":"9","author":"H Ullah","year":"2018","unstructured":"Ullah H, Khan H (2018) Anti-Parkinson potential of silymarin: mechanistic insight and therapeutic standing. Front Pharmacol 9:361297. https:\/\/doi.org\/10.3389\/FPHAR.2018.00422\/BIBTEX","journal-title":"Front Pharmacol"},{"key":"4654_CR45","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1007\/s00210-023-02776-z","volume":"397","author":"R Haddadi","year":"2024","unstructured":"Haddadi R, Eyvari-Brooshghalan S, Makhdoomi S et al (2024) Neuroprotective effects of silymarin in 3-nitropropionic acid-induced neurotoxicity in male mice: improving behavioral deficits by attenuating oxidative stress and neuroinflammation. Naunyn Schmiedebergs Arch Pharmacol 397:2447\u20132463. https:\/\/doi.org\/10.1007\/s00210-023-02776-z","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"4654_CR46","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/2008-2231-22-24","volume":"22","author":"P Yaghmaei","year":"2014","unstructured":"Yaghmaei P, Azarfar K, Dezfulian M, Ebrahim-Habibi A (2014) Silymarin effect on amyloid-\u03b2 plaque accumulation and gene expression of APP in an Alzheimer\u2019s disease rat model. DARU J Pharm Sci 22:24. https:\/\/doi.org\/10.1186\/2008-2231-22-24","journal-title":"DARU J Pharm Sci"},{"key":"4654_CR47","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1271\/BBB.100524","volume":"74","author":"NM Urata","year":"2010","unstructured":"Urata NM, Urakami KM, Zawa YO et al (2010) Silymarin attenuated the amyloid \u03b2 plaque burden and improved behavioral abnormalities in an Alzheimer\u2019s disease mouse model. Biosci Biotechnol Biochem 74:2299\u20132306. https:\/\/doi.org\/10.1271\/BBB.100524","journal-title":"Biosci Biotechnol Biochem"},{"key":"4654_CR48","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/J.BIOPHA.2017.06.018","volume":"93","author":"R Yuan","year":"2017","unstructured":"Yuan R, Fan H, Cheng S et al (2017) Silymarin prevents NLRP3 inflammasome activation and protects against intracerebral hemorrhage. Biomed Pharmacother 93:308\u2013315. https:\/\/doi.org\/10.1016\/J.BIOPHA.2017.06.018","journal-title":"Biomed Pharmacother"},{"key":"4654_CR49","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jep.2016.07.060","volume":"197","author":"S Gupta","year":"2017","unstructured":"Gupta S, Gupta YK (2017) Combination of Zizyphus jujuba and silymarin showed better neuroprotective effect as compared to single agent in MCAo-induced focal cerebral ischemia in rats. J Ethnopharmacol 197:118\u2013127. https:\/\/doi.org\/10.1016\/j.jep.2016.07.060","journal-title":"J Ethnopharmacol"},{"key":"4654_CR50","first-page":"182","volume":"7","author":"SK Das","year":"2008","unstructured":"Das SK, Mukherjee S, Vasudevan DM (2008) Medicinal properties of milk thistle with special reference to silymarin\u00f1 an overview. Nat Prod Radiance 7:182\u2013192","journal-title":"Nat Prod Radiance"},{"key":"4654_CR51","doi-asserted-by":"publisher","first-page":"46","DOI":"10.51227\/ojafr.2022.7","volume":"12","author":"WA Abd El-Ghany","year":"2022","unstructured":"Abd El-Ghany WA (2022) The potential uses of silymarin, a milk thistle (Silybum marianum) derivative, in poultry production system. Online J Anim Feed Res 12:46\u201352. https:\/\/doi.org\/10.51227\/ojafr.2022.7","journal-title":"Online J Anim Feed Res"},{"key":"4654_CR52","doi-asserted-by":"publisher","unstructured":"Macit M, Duman G, Cumbul A et al (2023) Formulation development of Silybum marianum seed extracts and silymarin nanoparticles, and evaluation of hepatoprotective effect. J Drug Deliv Sci Technol 83:. https:\/\/doi.org\/10.1016\/J.JDDST.2023.104378","DOI":"10.1016\/J.JDDST.2023.104378"},{"key":"4654_CR53","doi-asserted-by":"publisher","unstructured":"Neha, Jaggi AS, Singh N (2016) Silymarin and its role in chronic diseases. Adv Exp Med Biol 929:25\u201344. https:\/\/doi.org\/10.1007\/978-3-319-41342-6_2","DOI":"10.1007\/978-3-319-41342-6_2"},{"key":"4654_CR54","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.3390\/molecules22111942","volume":"22","author":"M Bijak","year":"2017","unstructured":"Bijak M (2017) Silybin, a major bioactive component of milk thistle (Silybum marianum L. Gaernt.)\u2014 chemistry, bioavailability, and metabolism. Molecules 22:1942. https:\/\/doi.org\/10.3390\/molecules22111942","journal-title":"Molecules"},{"key":"4654_CR55","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.5897\/JMPR12.0743","volume":"7","author":"A Elwekeel","year":"2013","unstructured":"Elwekeel A, Elfishawy A, Abouzid S (2013) Silymarin content in Silybum marianum fruits at different maturity stages. J Med Plants Res 7:1665\u20131669. https:\/\/doi.org\/10.5897\/JMPR12.0743","journal-title":"J Med Plants Res"},{"key":"4654_CR56","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1080\/10942912.2023.2244685","volume":"26","author":"MN Akhtar","year":"2023","unstructured":"Akhtar MN, Saeed R, Saeed F et al (2023) Silymarin: a review on paving the way towards promising pharmacological agent. Int J Food Prop 26:2256\u20132272. https:\/\/doi.org\/10.1080\/10942912.2023.2244685","journal-title":"Int J Food Prop"},{"key":"4654_CR57","doi-asserted-by":"publisher","first-page":"101775","DOI":"10.1016\/J.BCAB.2020.101775","volume":"29","author":"AA Elateeq","year":"2020","unstructured":"Elateeq AA, Sun Y, Nxumalo W, Gabr AMM (2020) Biotechnological production of silymarin in Silybum marianum L.: a review. Biocatal Agric Biotechnol 29:101775. https:\/\/doi.org\/10.1016\/J.BCAB.2020.101775","journal-title":"Biocatal Agric Biotechnol"},{"key":"4654_CR58","doi-asserted-by":"publisher","unstructured":"Choe U, Whent M, Luo Y, Yu L (Lucy) (2020) Total phenolic content, free radical scavenging capacity, and anti-cancer activity of silymarin. J Food Bioact 10:. https:\/\/doi.org\/10.31665\/JFB.2020.10226","DOI":"10.31665\/JFB.2020.10226"},{"key":"4654_CR59","doi-asserted-by":"publisher","first-page":"836","DOI":"10.15414\/JMBFS.2020.9.4.836-843","volume":"9","author":"V Valkov\u00e1","year":"2020","unstructured":"Valkov\u00e1 V, \u010e\u00faranov\u00e1 H, Bil\u010d\u00edkov\u00e1 J, Hab\u00e1n M (2020) Milk thistle (Silybum marianum): a valuable medicinal plant with several therapeutic purposes. J Microbiol Biotechnol Food Sci 9:836\u2013843. https:\/\/doi.org\/10.15414\/JMBFS.2020.9.4.836-843","journal-title":"J Microbiol Biotechnol Food Sci"},{"key":"4654_CR60","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/J.BIOPHA.2018.03.140","volume":"102","author":"A Taleb","year":"2018","unstructured":"Taleb A, Ahmad KA, Ihsan AU et al (2018) Antioxidant effects and mechanism of silymarin in oxidative stress induced cardiovascular diseases. Biomed Pharmacother 102:689\u2013698. https:\/\/doi.org\/10.1016\/J.BIOPHA.2018.03.140","journal-title":"Biomed Pharmacother"},{"key":"4654_CR61","doi-asserted-by":"publisher","first-page":"68","DOI":"10.20307\/NPS.2021.27.2.68","volume":"27","author":"LD Antika","year":"2021","unstructured":"Antika LD, Dewi RM (2021) The pharmacological properties of silymarin and its constituents. Nat Prod Sci 27:68\u201377. https:\/\/doi.org\/10.20307\/NPS.2021.27.2.68","journal-title":"Nat Prod Sci"},{"key":"4654_CR62","first-page":"239","volume":"16","author":"S Javed","year":"2011","unstructured":"Javed S, Kohli K, Ali M (2011) Reassessing bioavailability of silymarin. Altern Med Rev 16:239\u2013249","journal-title":"Altern Med Rev"},{"key":"4654_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S11101-013-9285-5\/FIGURES\/7","volume":"13","author":"E Theodosiou","year":"2014","unstructured":"Theodosiou E, Purchartov\u00e1 K, Stamatis H et al (2014) Bioavailability of silymarin flavonolignans: drug formulations and biotransformation. Phytochem Rev 13:1\u201318. https:\/\/doi.org\/10.1007\/S11101-013-9285-5\/FIGURES\/7","journal-title":"Phytochem Rev"},{"key":"4654_CR64","doi-asserted-by":"publisher","unstructured":"Di Costanzo A, Angelico R (2019) Formulation strategies for enhancing the bioavailability of silymarin: the state of the art. Molecules 24:. https:\/\/doi.org\/10.3390\/MOLECULES24112155","DOI":"10.3390\/MOLECULES24112155"},{"key":"4654_CR65","doi-asserted-by":"publisher","first-page":"111314","DOI":"10.1016\/j.foodres.2022.111314","volume":"156","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Li X, Sang S et al (2022) A review of nanostructured delivery systems for the encapsulation, protection, and delivery of silymarin: an emerging nutraceutical. Food Res Int 156:111314. https:\/\/doi.org\/10.1016\/j.foodres.2022.111314","journal-title":"Food Res Int"},{"key":"4654_CR66","doi-asserted-by":"publisher","first-page":"118824","DOI":"10.1016\/j.ijpharm.2019.118824","volume":"572","author":"MJ Sohrabi","year":"2019","unstructured":"Sohrabi MJ, Dehpour AR, Attar F et al (2019) Silymarin-albumin nanoplex: preparation and its potential application as an antioxidant in nervous system in vitro and in vivo. Int J Pharm 572:118824. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118824","journal-title":"Int J Pharm"},{"key":"4654_CR67","doi-asserted-by":"publisher","first-page":"105193","DOI":"10.1016\/j.chemphyslip.2022.105193","volume":"244","author":"A Singh","year":"2022","unstructured":"Singh A, Vaish A, Shukla R (2022) Box-Behnken design optimized silibinin loaded glycerylmonooleate nanoliquid crystal for brain targeting. Chem Phys Lipids 244:105193. https:\/\/doi.org\/10.1016\/j.chemphyslip.2022.105193","journal-title":"Chem Phys Lipids"},{"key":"4654_CR68","doi-asserted-by":"publisher","first-page":"535804","DOI":"10.3389\/fnins.2020.538404","volume":"14","author":"P Rathore","year":"2020","unstructured":"Rathore P, Arora I, Rastogi S et al (2020) Collagen nanoparticle-mediated brain silymarin delivery: an approach for treating cerebral ischemia and reperfusion-induced brain injury. Front Neurosci 14:535804. https:\/\/doi.org\/10.3389\/fnins.2020.538404","journal-title":"Front Neurosci"},{"key":"4654_CR69","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1080\/03639045.2022.2059498","volume":"47","author":"A Singh","year":"2021","unstructured":"Singh A, Ujjwal RR, Kumar A et al (2021) Formulation and optimization of silymarin-encapsulated binary micelles for enhanced amyloid disaggregation activity. Drug Dev Ind Pharm 47:1775\u20131785. https:\/\/doi.org\/10.1080\/03639045.2022.2059498","journal-title":"Drug Dev Ind Pharm"},{"key":"4654_CR70","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1166\/jbn.2021.3038","volume":"17","author":"Q Pan","year":"2021","unstructured":"Pan Q, Ban Y, Xu L (2021) Silibinin-albumin nanoparticles: characterization and biological evaluation against oxidative stress-stimulated neurotoxicity associated with Alzheimer\u2019s disease. J Biomed Nanotechnol 17:1123\u20131130. https:\/\/doi.org\/10.1166\/jbn.2021.3038","journal-title":"J Biomed Nanotechnol"},{"key":"4654_CR71","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/J.IJBIOMAC.2020.02.041","volume":"149","author":"A Singh","year":"2020","unstructured":"Singh A, Kumar A, Verma RK, Shukla R (2020) Silymarin encapsulated nanoliquid crystals for improved activity against beta amyloid induced cytotoxicity. Int J Biol Macromol 149:1198\u20131206. https:\/\/doi.org\/10.1016\/J.IJBIOMAC.2020.02.041","journal-title":"Int J Biol Macromol"},{"key":"4654_CR72","doi-asserted-by":"publisher","unstructured":"Saini V, Singh A, Shukla R et al (2022) Silymarin-encapsulated xanthan gum\u2013stabilized selenium nanocarriers for enhanced activity against amyloid fibril cytotoxicity. AAPS PharmSciTech 23:. https:\/\/doi.org\/10.1208\/S12249-022-02274-0","DOI":"10.1208\/S12249-022-02274-0"},{"key":"4654_CR73","doi-asserted-by":"publisher","first-page":"153260","DOI":"10.1016\/j.tox.2022.153260","volume":"477","author":"S Makhdoomi","year":"2022","unstructured":"Makhdoomi S, Mahboobian MM, Haddadi R et al (2022) Silibinin-loaded nanostructured lipid carriers (NLCs) ameliorated cognitive deficits and oxidative damages in aluminum chloride-induced neurotoxicity in male mice. Toxicology 477:153260. https:\/\/doi.org\/10.1016\/j.tox.2022.153260","journal-title":"Toxicology"},{"key":"4654_CR74","doi-asserted-by":"publisher","unstructured":"Imran M, Almehmadi M, Alsaiari AA et al (2023) Intranasal delivery of a silymarin loaded microemulsion for the effective treatment of Parkinson\u2019s disease in rats: formulation, optimization, characterization, and in vivo evaluation. Pharmaceutics 15:. https:\/\/doi.org\/10.3390\/PHARMACEUTICS15020618","DOI":"10.3390\/PHARMACEUTICS15020618"},{"key":"4654_CR75","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/CNS.12175","volume":"19","author":"A Borah","year":"2013","unstructured":"Borah A, Paul R, Choudhury S et al (2013) Neuroprotective potential of silymarin against CNS disorders: insight into the pathways and molecular mechanisms of action. CNS Neurosci Ther 19:847. https:\/\/doi.org\/10.1111\/CNS.12175","journal-title":"CNS Neurosci Ther"},{"key":"4654_CR76","doi-asserted-by":"publisher","unstructured":"Kesharwani SS, Jain V, Dey S et al (2020) An overview of advanced formulation and nanotechnology-based approaches for solubility and bioavailability enhancement of silymarin. J Drug Deliv Sci Technol 60:. https:\/\/doi.org\/10.1016\/J.JDDST.2020.102021","DOI":"10.1016\/J.JDDST.2020.102021"},{"key":"4654_CR77","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/J.JOB.2021.12.005","volume":"64","author":"AAB Eita","year":"2022","unstructured":"Eita AAB (2022) Milk thistle (Silybum marianum (L.) Gaertn.): an overview about its pharmacology and medicinal uses with an emphasis on oral diseases. J oral Biosci 64:71\u201376. https:\/\/doi.org\/10.1016\/J.JOB.2021.12.005","journal-title":"J oral Biosci"},{"key":"4654_CR78","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1002\/ptr.6361","volume":"33","author":"V Soleimani","year":"2019","unstructured":"Soleimani V, Delghandi PS, Moallem SA, Karimi G (2019) Safety and toxicity of silymarin, the major constituent of milk thistle extract: an updated review. Phyther Res 33:1627\u20131638. https:\/\/doi.org\/10.1002\/ptr.6361","journal-title":"Phyther Res"},{"key":"4654_CR79","first-page":"387","volume":"13","author":"J Geier","year":"1990","unstructured":"Geier J, Fuchs T, Wahl R (1990) Anaphylactic shock due to an extract of Silybum marianum in a patient with immediate-type allergy to kiwi fruit. Allergologie 13:387\u2013388","journal-title":"Allergologie"},{"key":"4654_CR80","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/J.1365-2893.2005.00636.X","volume":"12","author":"K\u00c9 Mayer","year":"2005","unstructured":"Mayer K\u00c9, Myers RP, Lee SS (2005) Silymarin treatment of viral hepatitis: a systematic review. J Viral Hepat 12:559\u2013567. https:\/\/doi.org\/10.1111\/J.1365-2893.2005.00636.X","journal-title":"J Viral Hepat"},{"key":"4654_CR81","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1016\/J.NEUROBIOLAGING.2015.02.002","volume":"36","author":"S Duan","year":"2015","unstructured":"Duan S, Guan X, Lin R et al (2015) Silibinin inhibits acetylcholinesterase activity and amyloid \u03b2 peptide aggregation: a dual-target drug for the treatment of Alzheimer\u2019s disease. Neurobiol Aging 36:1792\u20131807. https:\/\/doi.org\/10.1016\/J.NEUROBIOLAGING.2015.02.002","journal-title":"Neurobiol Aging"},{"key":"4654_CR82","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/S12576-019-00682-9","volume":"69","author":"D Bai","year":"2019","unstructured":"Bai D, Jin G, Zhang D et al (2019) Natural silibinin modulates amyloid precursor protein processing and amyloid-\u03b2 protein clearance in APP\/PS1 mice. J Physiol Sci 69:643\u2013652. https:\/\/doi.org\/10.1007\/S12576-019-00682-9","journal-title":"J Physiol Sci"},{"key":"4654_CR83","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/J.NEUINT.2010.12.017","volume":"58","author":"F Yin","year":"2011","unstructured":"Yin F, Liu J, Ji X et al (2011) Silibinin: a novel inhibitor of A\u03b2 aggregation. Neurochem Int 58:399\u2013403. https:\/\/doi.org\/10.1016\/J.NEUINT.2010.12.017","journal-title":"Neurochem Int"},{"key":"4654_CR84","doi-asserted-by":"publisher","first-page":"7141","DOI":"10.1007\/S00253-019-09950-5","volume":"103","author":"L Shen","year":"2019","unstructured":"Shen L, Liu L, Li XY, Ji HF (2019) Regulation of gut microbiota in Alzheimer\u2019s disease mice by silibinin and silymarin and their pharmacological implications. Appl Microbiol Biotechnol 103:7141\u20137149. https:\/\/doi.org\/10.1007\/S00253-019-09950-5","journal-title":"Appl Microbiol Biotechnol"},{"key":"4654_CR85","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2174\/1871527314666150116110212","volume":"14","author":"J Kumar","year":"2015","unstructured":"Kumar J, Park K-C, Awasthi A, Prasad B (2015) Silymarin extends lifespan and reduces proteotoxicity in C. elegans Alzheimer\u2019s model. CNS Neurol Disord Drug Targets 14:295\u2013302. https:\/\/doi.org\/10.2174\/1871527314666150116110212","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"4654_CR86","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1021\/acschemneuro.7b00110","volume":"8","author":"MFM Sciacca","year":"2017","unstructured":"Sciacca MFM, Romanucci V, Zarrelli A et al (2017) Inhibition of A\u03b2 amyloid growth and toxicity by silybins: the crucial role of stereochemistry. ACS Chem Neurosci 8:1767\u20131778. https:\/\/doi.org\/10.1021\/acschemneuro.7b00110","journal-title":"ACS Chem Neurosci"},{"key":"4654_CR87","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1271\/bbb.120925","volume":"77","author":"M Sato","year":"2013","unstructured":"Sato M, Murakami K, Uno M et al (2013) Structure-activity relationship for (+)-taxifolin isolated from silymarin as an inhibitor of amyloid \u03b2 aggregation. Biosci Biotechnol Biochem 77:1100\u20131103. https:\/\/doi.org\/10.1271\/bbb.120925","journal-title":"Biosci Biotechnol Biochem"},{"key":"4654_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1326-6-27\/FIGURES\/2","volume":"6","author":"H Zheng","year":"2011","unstructured":"Zheng H, Koo EH (2011) Biology and pathophysiology of the amyloid precursor protein. Mol Neurodegener 6:1\u201316. https:\/\/doi.org\/10.1186\/1750-1326-6-27\/FIGURES\/2","journal-title":"Mol Neurodegener"},{"key":"4654_CR89","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1007\/S11064-018-2481-3","volume":"43","author":"X Song","year":"2018","unstructured":"Song X, Liu B, Cui L et al (2018) Estrogen receptors are involved in the neuroprotective effect of silibinin in A\u03b21-42-treated rats. Neurochem Res 43:796\u2013805. https:\/\/doi.org\/10.1007\/S11064-018-2481-3","journal-title":"Neurochem Res"},{"issue":"6","key":"4654_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S40035-017-0093-5","volume":"61","author":"B Das","year":"2017","unstructured":"Das B (2017) Yan R (2017) Role of BACE1 in Alzheimer\u2019s synaptic function. Transl Neurodegener 61(6):1\u20138. https:\/\/doi.org\/10.1186\/S40035-017-0093-5","journal-title":"Transl Neurodegener"},{"key":"4654_CR91","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/J.NBD.2006.12.008","volume":"26","author":"M Ohno","year":"2007","unstructured":"Ohno M, Cole SL, Yasvoina M et al (2007) BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP\/PS1 transgenic mice. Neurobiol Dis 26:134\u2013145. https:\/\/doi.org\/10.1016\/J.NBD.2006.12.008","journal-title":"Neurobiol Dis"},{"key":"4654_CR92","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0304-3940(00)01675-X","volume":"297","author":"K Yasojima","year":"2001","unstructured":"Yasojima K, Akiyama H, McGeer EG, McGeer PL (2001) Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of beta-amyloid peptide. Neurosci Lett 297:97\u2013100. https:\/\/doi.org\/10.1016\/S0304-3940(00)01675-X","journal-title":"Neurosci Lett"},{"key":"4654_CR93","doi-asserted-by":"publisher","first-page":"12841","DOI":"10.3390\/ijms232112841","volume":"23","author":"P Rawat","year":"2022","unstructured":"Rawat P, Sehar U, Bisht J et al (2022) Phosphorylated tau in Alzheimer\u2019s disease and other tauopathies. Int J Mol Sci 23:12841. https:\/\/doi.org\/10.3390\/ijms232112841","journal-title":"Int J Mol Sci"},{"key":"4654_CR94","doi-asserted-by":"publisher","unstructured":"Liu P, Cui L, Liu B et al (2020) Silibinin ameliorates STZ-induced impairment of memory and learning by up- regulating insulin signaling pathway and attenuating apoptosis. Physiol Behav 213:. https:\/\/doi.org\/10.1016\/J.PHYSBEH.2019.112689","DOI":"10.1016\/J.PHYSBEH.2019.112689"},{"key":"4654_CR95","doi-asserted-by":"publisher","unstructured":"Liu P, Wang C, Chen W et al (2023) Inhibition of GluN2B pathway is involved in the neuroprotective effect of silibinin on streptozotocin-induced Alzheimer\u2019s disease models. Phytomedicine 109:. https:\/\/doi.org\/10.1016\/J.PHYMED.2022.154594","DOI":"10.1016\/J.PHYMED.2022.154594"},{"key":"4654_CR96","doi-asserted-by":"publisher","unstructured":"Wei P, Li X, Wang S et al (2022) Silibinin ameliorates formaldehyde-induced cognitive impairment by inhibiting oxidative stress. Oxid Med Cell Longev 2022:. https:\/\/doi.org\/10.1155\/2022\/5981353","DOI":"10.1155\/2022\/5981353"},{"key":"4654_CR97","doi-asserted-by":"publisher","unstructured":"Guo H, Cao H, Cui X et al (2019) Silymarin\u2019s inhibition and treatment effects for Alzheimer\u2019s disease. Molecules 24:. https:\/\/doi.org\/10.3390\/MOLECULES24091748","DOI":"10.3390\/MOLECULES24091748"},{"key":"4654_CR98","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/j.1742-4658.2007.06238.x","volume":"275","author":"NC Inestrosa","year":"2008","unstructured":"Inestrosa NC, Dinamarca MC, Alvarez A (2008) Amyloid-cholinesterase interactions: implications for Alzheimer\u2019s disease. FEBS J 275:625\u2013632. https:\/\/doi.org\/10.1111\/j.1742-4658.2007.06238.x","journal-title":"FEBS J"},{"key":"4654_CR99","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.2174\/092986708784310422","volume":"15","author":"M Loizzo","year":"2008","unstructured":"Loizzo M, Tundis R, Menichini F, Menichini F (2008) Natural products and their derivatives as cholinesterase inhibitors in the treatment of neurodegenerative disorders: an update. Curr Med Chem 15:1209\u20131228. https:\/\/doi.org\/10.2174\/092986708784310422","journal-title":"Curr Med Chem"},{"key":"4654_CR100","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0014-5793(99)00468-8","volume":"450","author":"FJ Mu\u00f1oz","year":"1999","unstructured":"Mu\u00f1oz FJ, Inestrosa NC (1999) Neurotoxicity of acetylcholinesterase amyloid beta-peptide aggregates is dependent on the type of Abeta peptide and the AChE concentration present in the complexes. FEBS Lett 450:205\u2013209. https:\/\/doi.org\/10.1016\/S0014-5793(99)00468-8","journal-title":"FEBS Lett"},{"key":"4654_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/AGEING\/9.1.1","volume":"9","author":"EK Perry","year":"1980","unstructured":"Perry EK (1980) The cholinergic system in old age and Alzheimer\u2019s disease. Age Ageing 9:1\u20138. https:\/\/doi.org\/10.1093\/AGEING\/9.1.1","journal-title":"Age Ageing"},{"key":"4654_CR102","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1046\/J.1471-4159.2003.01985.X","volume":"87","author":"MA Chac\u00f3n","year":"2003","unstructured":"Chac\u00f3n MA, Reyes AE, Inestrosa NC (2003) Acetylcholinesterase induces neuronal cell loss, astrocyte hypertrophy and behavioral deficits in mammalian hippocampus. J Neurochem 87:195\u2013204. https:\/\/doi.org\/10.1046\/J.1471-4159.2003.01985.X","journal-title":"J Neurochem"},{"key":"4654_CR103","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.3892\/mmr.2019.10374","volume":"20","author":"K Sharma","year":"2019","unstructured":"Sharma K (2019) Cholinesterase inhibitors as Alzheimer\u2019s therapeutics (review). Mol Med Rep 20:1479\u20131487. https:\/\/doi.org\/10.3892\/mmr.2019.10374","journal-title":"Mol Med Rep"},{"key":"4654_CR104","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/J.JEP.2017.08.026","volume":"210","author":"N Nazir","year":"2018","unstructured":"Nazir N, Karim N, Abdel-Halim H et al (2018) Phytochemical analysis, molecular docking and antiamnesic effects of methanolic extract of Silybum marianum (L.) Gaertn seeds in scopolamine induced memory impairment in mice. J Ethnopharmacol 210:198\u2013208. https:\/\/doi.org\/10.1016\/J.JEP.2017.08.026","journal-title":"J Ethnopharmacol"},{"key":"4654_CR105","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1515\/znc-2007-11-1210","volume":"62","author":"I Orhan","year":"2007","unstructured":"Orhan I, Kartal M, Tosun F, \u015eener B (2007) Screening of various phenolic acids and flavonoid derivatives for their anticholinesterase potential. Zeitschrift fur Naturforsch - Sect C J Biosci 62:829\u2013832. https:\/\/doi.org\/10.1515\/znc-2007-11-1210","journal-title":"Zeitschrift fur Naturforsch - Sect C J Biosci"},{"key":"4654_CR106","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s12640-023-00648-1","volume":"41","author":"ME Shah-abadi","year":"2023","unstructured":"Shah-abadi ME, Ariaei A, Moradi F et al (2023) In silico interactions of natural and synthetic compounds with key proteins involved in Alzheimer\u2019s disease: prospects for designing new therapeutics compound. Neurotox Res 41:408\u2013430. https:\/\/doi.org\/10.1007\/s12640-023-00648-1","journal-title":"Neurotox Res"},{"key":"4654_CR107","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/S11064-011-0632-X","volume":"37","author":"Y Chtourou","year":"2012","unstructured":"Chtourou Y, Fetoui H, Garoui EM et al (2012) Improvement of cerebellum redox states and cholinergic functions contribute to the beneficial effects of silymarin against manganese-induced neurotoxicity. Neurochem Res 37:469\u2013479. https:\/\/doi.org\/10.1007\/S11064-011-0632-X","journal-title":"Neurochem Res"},{"key":"4654_CR108","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.3889\/OAMJMS.2018.257","volume":"6","author":"SA El-Marasy","year":"2018","unstructured":"El-Marasy SA, Abd-Elsalam RM, Ahmed-Farid OA (2018) Ameliorative effect of silymarin on scopolamine-induced dementia in rats. Open Access Maced J Med Sci 6:1215. https:\/\/doi.org\/10.3889\/OAMJMS.2018.257","journal-title":"Open Access Maced J Med Sci"},{"key":"4654_CR109","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/J.NEURON.2014.03.030","volume":"82","author":"MP Parsons","year":"2014","unstructured":"Parsons MP, Raymond LA (2014) Extrasynaptic NMDA receptor involvement in central nervous system disorders. Neuron 82:279\u2013293. https:\/\/doi.org\/10.1016\/J.NEURON.2014.03.030","journal-title":"Neuron"},{"key":"4654_CR110","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3233\/JAD-160763","volume":"57","author":"R Wang","year":"2017","unstructured":"Wang R, Reddy PH (2017) Role of glutamate and NMDA receptors in Alzheimer\u2019s disease. J Alzheimer\u2019s Dis 57:1041\u20131048. https:\/\/doi.org\/10.3233\/JAD-160763","journal-title":"J Alzheimer\u2019s Dis"},{"key":"4654_CR111","doi-asserted-by":"publisher","first-page":"11832","DOI":"10.1523\/JNEUROSCI.3478-07.2007","volume":"27","author":"DV Venkitaramani","year":"2007","unstructured":"Venkitaramani DV, Chin J, Netzer WJ et al (2007) \u03b2-amyloid modulation of synaptic transmission and plasticity. J Neurosci 27:11832\u201311837. https:\/\/doi.org\/10.1523\/JNEUROSCI.3478-07.2007","journal-title":"J Neurosci"},{"key":"4654_CR112","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/jnr.21548","volume":"86","author":"EM Kawamoto","year":"2008","unstructured":"Kawamoto EM, Lepsch LB, Boaventura MFC et al (2008) Amyloid \u03b2-peptide activates nuclear factor-\u03baB through an N-methyl-D-aspartate signaling pathway in cultured cerebellar cells. J Neurosci Res 86:845\u2013860. https:\/\/doi.org\/10.1002\/jnr.21548","journal-title":"J Neurosci Res"},{"key":"4654_CR113","doi-asserted-by":"publisher","first-page":"109","DOI":"10.12729\/JBTR.2016.17.4.109","volume":"17","author":"HM Lee","year":"2016","unstructured":"Lee HM, Jang JY, Seong H, Seong YH (2016) Protective effect of the aerial parts of Silybum marianum against amyloid \u03b2 protein (25\u201335)-induced neuronal death in cultured neurons. J Biomed Transl Res 17:109\u2013114. https:\/\/doi.org\/10.12729\/JBTR.2016.17.4.109","journal-title":"J Biomed Transl Res"},{"key":"4654_CR114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/BIOMEDICINES8110486","volume":"8","author":"CW Lu","year":"2020","unstructured":"Lu CW, Lin TY, Chiu KM et al (2020) Silymarin inhibits glutamate release and prevents against kainic acid-induced excitotoxic injury in rats. Biomedicines 8:1\u201322. https:\/\/doi.org\/10.3390\/BIOMEDICINES8110486","journal-title":"Biomedicines"},{"key":"4654_CR115","doi-asserted-by":"publisher","first-page":"1281338","DOI":"10.3389\/FNAGI.2023.1281338\/BIBTEX","volume":"15","author":"H Barmaki","year":"2023","unstructured":"Barmaki H, Nourazarian A, Khaki-Khatibi F (2023) Proteostasis and neurodegeneration: a closer look at autophagy in Alzheimer\u2019s disease. Front Aging Neurosci 15:1281338. https:\/\/doi.org\/10.3389\/FNAGI.2023.1281338\/BIBTEX","journal-title":"Front Aging Neurosci"},{"key":"4654_CR116","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/J.APSB.2022.01.008","volume":"12","author":"W Zhang","year":"2022","unstructured":"Zhang W, Xu C, Sun J et al (2022) Impairment of the autophagy\u2013lysosomal pathway in Alzheimer\u2019s diseases: pathogenic mechanisms and therapeutic potential. Acta Pharm Sin B 12:1019. https:\/\/doi.org\/10.1016\/J.APSB.2022.01.008","journal-title":"Acta Pharm Sin B"},{"key":"4654_CR117","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1385\/NMM:4:1-2:21","volume":"4","author":"M Hashimoto","year":"2003","unstructured":"Hashimoto M, Rockenstein E, Crews L, Masliah E (2003) Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer\u2019s and Parkinson\u2019s diseases. Neuromolecular Med 4:21\u201335. https:\/\/doi.org\/10.1385\/NMM:4:1-2:21","journal-title":"Neuromolecular Med"},{"key":"4654_CR118","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/J.CUB.2018.12.021","volume":"29","author":"M Glatigny","year":"2019","unstructured":"Glatigny M, Moriceau S, Rivagorda M et al (2019) Autophagy is required for memory formation and reverses age-related memory decline. Curr Biol 29:435-448.e8. https:\/\/doi.org\/10.1016\/J.CUB.2018.12.021","journal-title":"Curr Biol"},{"key":"4654_CR119","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/S11064-016-2141-4","volume":"42","author":"X Song","year":"2017","unstructured":"Song X, Zhou B, Cui L et al (2017) Silibinin ameliorates A\u03b225-35-induced memory deficits in rats by modulating autophagy and attenuating neuroinflammation as well as oxidative stress. Neurochem Res 42:1073\u20131083. https:\/\/doi.org\/10.1007\/S11064-016-2141-4","journal-title":"Neurochem Res"},{"key":"4654_CR120","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/J.PHYSBEH.2017.07.023","volume":"179","author":"X Song","year":"2017","unstructured":"Song X, Liu B, Cui L et al (2017) Silibinin ameliorates anxiety\/depression-like behaviors in amyloid \u03b2-treated rats by upregulating BDNF\/TrkB pathway and attenuating autophagy in hippocampus. Physiol Behav 179:487\u2013493. https:\/\/doi.org\/10.1016\/J.PHYSBEH.2017.07.023","journal-title":"Physiol Behav"},{"key":"4654_CR121","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1007\/S11064-014-1454-4","volume":"39","author":"M Obulesu","year":"2014","unstructured":"Obulesu M, Lakshmi MJ (2014) Apoptosis in Alzheimer\u2019s disease: an understanding of the physiology, pathology and therapeutic avenues. Neurochem Res 39:2301\u20132312. https:\/\/doi.org\/10.1007\/S11064-014-1454-4","journal-title":"Neurochem Res"},{"key":"4654_CR122","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1007\/S11064-021-03418-7","volume":"46","author":"VK Sharma","year":"2021","unstructured":"Sharma VK, Singh TG, Singh S et al (2021) Apoptotic pathways and Alzheimer\u2019s disease: probing therapeutic potential. Neurochem Res 46:3103\u20133122. https:\/\/doi.org\/10.1007\/S11064-021-03418-7","journal-title":"Neurochem Res"},{"key":"4654_CR123","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/S10495-023-01848-Y","volume":"28","author":"S Kumari","year":"2023","unstructured":"Kumari S, Dhapola R, Reddy DHK (2023) Apoptosis in Alzheimer\u2019s disease: insight into the signaling pathways and therapeutic avenues. Apoptosis 28:943\u2013957. https:\/\/doi.org\/10.1007\/S10495-023-01848-Y","journal-title":"Apoptosis"},{"key":"4654_CR124","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1007\/S11064-019-02816-2","volume":"44","author":"B Liu","year":"2019","unstructured":"Liu B, Liu W, Liu P et al (2019) Silibinin alleviates the learning and memory defects in overtrained rats accompanying reduced neuronal apoptosis and senescence. Neurochem Res 44:1818\u20131829. https:\/\/doi.org\/10.1007\/S11064-019-02816-2","journal-title":"Neurochem Res"},{"key":"4654_CR125","doi-asserted-by":"publisher","first-page":"109691","DOI":"10.1016\/j.abb.2023.109691","volume":"744","author":"P Liu","year":"2023","unstructured":"Liu P, Chen W, Kang Y et al (2023) Silibinin ameliorates STING-mediated neuroinflammation via downregulation of ferroptotic damage in a sporadic Alzheimer\u2019s disease model. Arch Biochem Biophys 744:109691. https:\/\/doi.org\/10.1016\/j.abb.2023.109691","journal-title":"Arch Biochem Biophys"},{"key":"4654_CR126","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3233\/JAD-2004-6211","volume":"6","author":"MC Polidori","year":"2004","unstructured":"Polidori MC (2004) Oxidative stress and risk factors for Alzheimer\u2019s disease: clues to prevention and therapy. J Alzheimer\u2019s Dis 6:185\u2013191. https:\/\/doi.org\/10.3233\/JAD-2004-6211","journal-title":"J Alzheimer\u2019s Dis"},{"key":"4654_CR127","first-page":"21","volume":"149","author":"PF Good","year":"1996","unstructured":"Good PF, Werner P, Hsu A et al (1996) Evidence for neuronal oxidative damage in Alzheimer\u2019s disease. Am J Pathol 149:21\u201328","journal-title":"Am J Pathol"},{"key":"4654_CR128","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3233\/JAD-2007-12107","volume":"12","author":"DA Butterfield","year":"2007","unstructured":"Butterfield DA, Sultana R (2007) Redox proteomics identification of oxidatively modified brain proteins in Alzheimer\u2019s disease and mild cognitive impairment: insights into the progression of this dementing disorder. J Alzheimer\u2019s Dis 12:61\u201372. https:\/\/doi.org\/10.3233\/JAD-2007-12107","journal-title":"J Alzheimer\u2019s Dis"},{"key":"4654_CR129","doi-asserted-by":"publisher","first-page":"102294","DOI":"10.1016\/j.ctim.2019.102294","volume":"49","author":"L Cassidy","year":"2020","unstructured":"Cassidy L, Fernandez F, Johnson JB et al (2020) Oxidative stress in alzheimer\u2019s disease: a review on emergent natural polyphenolic therapeutics. Complement Ther Med 49:102294. https:\/\/doi.org\/10.1016\/j.ctim.2019.102294","journal-title":"Complement Ther Med"},{"key":"4654_CR130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-29770-3","volume":"8","author":"P Youssef","year":"2018","unstructured":"Youssef P, Chami B, Lim J et al (2018) Evidence supporting oxidative stress in a moderately affected area of the brain in Alzheimer\u2019s disease. Sci Rep 8:1\u201314. https:\/\/doi.org\/10.1038\/s41598-018-29770-3","journal-title":"Sci Rep"},{"key":"4654_CR131","first-page":"18745","volume":"25","author":"MMAZH AhlamAbdalla","year":"2021","unstructured":"AhlamAbdalla MMAZH (2021) Molecular mechanisms involved in the ameliorative effect of silymarin against experimentally-induced Alzheimer disease in rats. Ann Rom Soc Cell Biol 25:18745\u201318757","journal-title":"Ann Rom Soc Cell Biol"},{"key":"4654_CR132","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/S00210-014-0990-4","volume":"387","author":"KA Neha","year":"2014","unstructured":"Neha KA, Jaggi AS et al (2014) Silymarin ameliorates memory deficits and neuropathological changes in mouse model of high-fat-diet-induced experimental dementia. Naunyn Schmiedebergs Arch Pharmacol 387:777\u2013787. https:\/\/doi.org\/10.1007\/S00210-014-0990-4","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"4654_CR133","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/J.PATHOPHYS.2017.01.002","volume":"24","author":"Y Onaolapo Adejoke","year":"2017","unstructured":"Onaolapo Adejoke Y, Abdusalam Saratu Z, Onaolapo Olakunle J (2017) Silymarin attenuates aspartame-induced variation in mouse behaviour, cerebrocortical morphology and oxidative stress markers. Pathophysiol Off J Int Soc Pathophysiol 24:51\u201362. https:\/\/doi.org\/10.1016\/J.PATHOPHYS.2017.01.002","journal-title":"Pathophysiol Off J Int Soc Pathophysiol"},{"key":"4654_CR134","first-page":"35","volume":"15","author":"M Roghani","year":"2013","unstructured":"Roghani M, Khalili M, Baluchnejadmojarad T, Ahmadi M (2013) Protective effect of silymarin on learning and memory deficiency in streptozotocin-diabetic Rats. J Gorgan Univ Med Sci 15:35\u201341","journal-title":"J Gorgan Univ Med Sci"},{"key":"4654_CR135","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1111\/J.1476-5381.2009.00295.X","volume":"157","author":"P Lu","year":"2009","unstructured":"Lu P, Mamiya T, Lu LL et al (2009) Silibinin prevents amyloid beta peptide-induced memory impairment and oxidative stress in mice. Br J Pharmacol 157:1270\u20131277. https:\/\/doi.org\/10.1111\/J.1476-5381.2009.00295.X","journal-title":"Br J Pharmacol"},{"key":"4654_CR136","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1016\/J.FCT.2009.07.030","volume":"47","author":"F Galhardi","year":"2009","unstructured":"Galhardi F, Mesquita K, Monserrat JM, Barros DM (2009) Effect of silymarin on biochemical parameters of oxidative stress in aged and young rat brain. Food Chem Toxicol 47:2655\u20132660. https:\/\/doi.org\/10.1016\/J.FCT.2009.07.030","journal-title":"Food Chem Toxicol"},{"key":"4654_CR137","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/J.PHYMED.2006.02.005","volume":"14","author":"C Nencini","year":"2007","unstructured":"Nencini C, Giorgi G, Micheli L (2007) Protective effect of silymarin on oxidative stress in rat brain. Phytomedicine 14:129\u2013135. https:\/\/doi.org\/10.1016\/J.PHYMED.2006.02.005","journal-title":"Phytomedicine"},{"key":"4654_CR138","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1080\/01480545.2018.1544984","volume":"42","author":"NM Ali","year":"2019","unstructured":"Ali NM, Mahmoud AAA, Mahmoud MF, El Fayoumi HM (2019) Glycyrrhizic acid and silymarin alleviate the neurotoxic effects of aluminum in rats challenged with fructose-induced insulin resistance: possible role of toll-like receptor 4 pathway. Drug Chem Toxicol 42:210\u2013219. https:\/\/doi.org\/10.1080\/01480545.2018.1544984","journal-title":"Drug Chem Toxicol"},{"key":"4654_CR139","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/J.NEULET.2016.08.043","volume":"632","author":"J Zhou","year":"2016","unstructured":"Zhou J, Chao G, Li YL et al (2016) Activation of NRF2\/ARE by isosilybin alleviates A\u03b225-35-induced oxidative stress injury in HT-22 cells. Neurosci Lett 632:92\u201397. https:\/\/doi.org\/10.1016\/J.NEULET.2016.08.043","journal-title":"Neurosci Lett"},{"key":"4654_CR140","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s41232-023-00277-3","volume":"43","author":"A Sobue","year":"2023","unstructured":"Sobue A, Komine O, Yamanaka K (2023) Neuroinflammation in Alzheimer\u2019s disease: microglial signature and their relevance to disease. Inflamm Regen 43:26. https:\/\/doi.org\/10.1186\/s41232-023-00277-3","journal-title":"Inflamm Regen"},{"key":"4654_CR141","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng F, Edison P (2021) Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol 17:157\u2013172. https:\/\/doi.org\/10.1038\/s41582-020-00435-y","journal-title":"Nat Rev Neurol"},{"key":"4654_CR142","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/J.NEULET.2016.06.008","volume":"629","author":"G Jin","year":"2016","unstructured":"Jin G, Bai D, Yin S et al (2016) Silibinin rescues learning and memory deficits by attenuating microglia activation and preventing neuroinflammatory reactions in SAMP8 mice. Neurosci Lett 629:256\u2013261. https:\/\/doi.org\/10.1016\/J.NEULET.2016.06.008","journal-title":"Neurosci Lett"},{"key":"4654_CR143","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/J.NEUINT.2010.09.005","volume":"57","author":"MJ Tsai","year":"2010","unstructured":"Tsai MJ, Liao JF, Lin DY et al (2010) Silymarin protects spinal cord and cortical cells against oxidative stress and lipopolysaccharide stimulation. Neurochem Int 57:867\u2013875. https:\/\/doi.org\/10.1016\/J.NEUINT.2010.09.005","journal-title":"Neurochem Int"},{"key":"4654_CR144","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/BRAINSCI10090628","volume":"10","author":"HR Aboelwafa","year":"2020","unstructured":"Aboelwafa HR, El-Kott AF, Abd-Ella EM, Yousef HN (2020) The possible neuroprotective effect of silymarin against aluminum chloride-prompted Alzheimer\u2019s-like disease in rats. Brain Sci 10:1\u201321. https:\/\/doi.org\/10.3390\/BRAINSCI10090628","journal-title":"Brain Sci"},{"key":"4654_CR145","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1124\/JPET.109.155069","volume":"331","author":"P Lu","year":"2009","unstructured":"Lu P, Mamiya T, Lu LL et al (2009) Silibinin attenuates amyloid beta(25\u201335) peptide-induced memory impairments: implication of inducible nitric-oxide synthase and tumor necrosis factor-alpha in mice. J Pharmacol Exp Ther 331:319\u2013326. https:\/\/doi.org\/10.1124\/JPET.109.155069","journal-title":"J Pharmacol Exp Ther"},{"key":"4654_CR146","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-161141","volume":"58","author":"C Jiang","year":"2017","unstructured":"Jiang C, Li G, Huang P et al (2017) The gut microbiota and Alzheimer\u2019s disease. J Alzheimers Dis 58:1\u201315. https:\/\/doi.org\/10.3233\/JAD-161141","journal-title":"J Alzheimers Dis"},{"key":"4654_CR147","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/J.BBR.2009.10.024","volume":"207","author":"P Lu","year":"2010","unstructured":"Lu P, Mamiya T, Lu L et al (2010) Silibinin attenuates cognitive deficits and decreases of dopamine and serotonin induced by repeated methamphetamine treatment. Behav Brain Res 207:387\u2013393. https:\/\/doi.org\/10.1016\/J.BBR.2009.10.024","journal-title":"Behav Brain Res"},{"key":"4654_CR148","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/J.JFF.2017.01.029","volume":"31","author":"S Srivastava","year":"2017","unstructured":"Srivastava S, Sammi SR, Laxman TS et al (2017) Silymarin promotes longevity and alleviates Parkinson\u2019s associated pathologies in Caenorhabditis elegans. J Funct Foods 31:32\u201343. https:\/\/doi.org\/10.1016\/J.JFF.2017.01.029","journal-title":"J Funct Foods"},{"key":"4654_CR149","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/J.BRAINRES.2015.09.029","volume":"1627","author":"Y Lee","year":"2015","unstructured":"Lee Y, Chun HJ, Lee KM et al (2015) Silibinin suppresses astroglial activation in a mouse model of acute Parkinson\u2019s disease by modulating the ERK and JNK signaling pathways. Brain Res 1627:233\u2013242. https:\/\/doi.org\/10.1016\/J.BRAINRES.2015.09.029","journal-title":"Brain Res"},{"key":"4654_CR150","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/J.NEULET.2010.06.038","volume":"480","author":"T Baluchnejadmojarad","year":"2010","unstructured":"Baluchnejadmojarad T, Roghani M, Mafakheri M (2010) Neuroprotective effect of silymarin in 6-hydroxydopamine hemi-parkinsonian rat: involvement of estrogen receptors and oxidative stress. Neurosci Lett 480:206\u2013210. https:\/\/doi.org\/10.1016\/J.NEULET.2010.06.038","journal-title":"Neurosci Lett"},{"key":"4654_CR151","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.neulet.2013.09.022","volume":"555","author":"R Haddadi","year":"2013","unstructured":"Haddadi R, Mohajjel Nayebi A, Brooshghalan SE (2013) Pre-treatment with silymarin reduces brain myeloperoxidase activity and inflammatory cytokines in 6-OHDA hemi-parkinsonian rats. Neurosci Lett 555:106\u2013111. https:\/\/doi.org\/10.1016\/j.neulet.2013.09.022","journal-title":"Neurosci Lett"},{"key":"4654_CR152","doi-asserted-by":"publisher","first-page":"463","DOI":"10.15171\/apb.2015.063","volume":"5","author":"R Haddadi","year":"2015","unstructured":"Haddadi R, Brooshghalan SE, Farajniya S et al (2015) Short-term treatment with silymarin improved 6-OHDA-induced catalepsy and motor imbalance in hemi-parkisonian rats. Adv Pharm Bull 5:463\u2013469. https:\/\/doi.org\/10.15171\/apb.2015.063","journal-title":"Adv Pharm Bull"},{"key":"4654_CR153","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/2008-2231-22-38","volume":"22","author":"R Haddadi","year":"2014","unstructured":"Haddadi R, Nayebi AM, Farajniya S et al (2014) Silymarin improved 6-OHDA-induced motor impairment in hemi-parkisonian rats: behavioral and molecular study. DARU, J Pharm Sci 22:38. https:\/\/doi.org\/10.1186\/2008-2231-22-38","journal-title":"DARU, J Pharm Sci"},{"key":"4654_CR154","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/J.TOX.2014.02.009","volume":"319","author":"J P\u00e9rez-H","year":"2014","unstructured":"P\u00e9rez-H J, Carrillo-S C, Garc\u00eda E et al (2014) Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson\u2019s disease. Toxicology 319:38\u201343. https:\/\/doi.org\/10.1016\/J.TOX.2014.02.009","journal-title":"Toxicology"},{"key":"4654_CR155","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1600-079X.2010.00819.x","volume":"50","author":"NK Singhal","year":"2011","unstructured":"Singhal NK, Srivastava G, Patel DK et al (2011) Melatonin or silymarin reduces maneb- and paraquat-induced Parkinsons disease phenotype in the mouse. J Pineal Res 50:97\u2013109. https:\/\/doi.org\/10.1111\/j.1600-079X.2010.00819.x","journal-title":"J Pineal Res"},{"key":"4654_CR156","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1007\/S11010-022-04620-Z","volume":"478","author":"G Singh","year":"2023","unstructured":"Singh G, Mittra N, Singh C (2023) Tempol and silymarin rescue from zinc-induced degeneration of dopaminergic neurons through modulation of oxidative stress and inflammation. Mol Cell Biochem 478:1705\u20131718. https:\/\/doi.org\/10.1007\/S11010-022-04620-Z","journal-title":"Mol Cell Biochem"},{"key":"4654_CR157","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.3390\/cells9071687","volume":"9","author":"M Pajares","year":"2020","unstructured":"Pajares M, Rojo IA, Manda G et al (2020) Inflammation in Parkinson\u2019s disease: mechanisms and therapeutic implications. Cells 9:1687. https:\/\/doi.org\/10.3390\/cells9071687","journal-title":"Cells"},{"key":"4654_CR158","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, Wallings RL, Houser MC et al (2022) Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol 22:657\u2013673. https:\/\/doi.org\/10.1038\/s41577-022-00684-6","journal-title":"Nat Rev Immunol"},{"key":"4654_CR159","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.fct.2018.05.062","volume":"118","author":"CM de Freitas","year":"2018","unstructured":"de Freitas CM, Krum BN, Chiapinotto Ceretta AP et al (2018) Silymarin recovers 6-hydroxydopamine-induced motor deficits in mice. Food Chem Toxicol 118:549\u2013556. https:\/\/doi.org\/10.1016\/j.fct.2018.05.062","journal-title":"Food Chem Toxicol"},{"key":"4654_CR160","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1046\/J.1460-9568.2002.02290.X","volume":"16","author":"MJ Wang","year":"2002","unstructured":"Wang MJ, Lin WW, Chen HL et al (2002) Silymarin protects dopaminergic neurons against lipopolysaccharide-induced neurotoxicity by inhibiting microglia activation. Eur J Neurosci 16:2103\u20132112. https:\/\/doi.org\/10.1046\/J.1460-9568.2002.02290.X","journal-title":"Eur J Neurosci"},{"key":"4654_CR161","doi-asserted-by":"publisher","first-page":"113593","DOI":"10.1016\/j.physbeh.2021.113593","volume":"241","author":"X Liu","year":"2021","unstructured":"Liu X, Chen W, Wang C et al (2021) Silibinin ameliorates depression\/anxiety-like behaviors of Parkinson\u2019s disease mouse model and is associated with attenuated STING-IRF3-IFN-\u03b2 pathway activation and neuroinflammation. Physiol Behav 241:113593. https:\/\/doi.org\/10.1016\/j.physbeh.2021.113593","journal-title":"Physiol Behav"},{"key":"4654_CR162","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11010-013-1780-x","volume":"384","author":"NK Singhal","year":"2013","unstructured":"Singhal NK, Chauhan AK, Jain SK et al (2013) Silymarin- and melatonin-mediated changes in the expression of selected genes in pesticides-induced Parkinsonism. Mol Cell Biochem 384:47\u201358. https:\/\/doi.org\/10.1007\/s11010-013-1780-x","journal-title":"Mol Cell Biochem"},{"key":"4654_CR163","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/S12031-019-01431-8","volume":"70","author":"MK Tripathi","year":"2020","unstructured":"Tripathi MK, Rasheed MSU, Mishra AK et al (2020) Silymarin protects against impaired autophagy associated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism. J Mol Neurosci 70:276\u2013283. https:\/\/doi.org\/10.1007\/S12031-019-01431-8","journal-title":"J Mol Neurosci"},{"key":"4654_CR164","doi-asserted-by":"publisher","first-page":"11644","DOI":"10.1021\/ACS.JAFC.0C04791\/ASSET\/IMAGES\/MEDIUM\/JF0C04791_0007.GIF","volume":"68","author":"X Wang","year":"2020","unstructured":"Wang X, Zhang Z, Wu SC (2020) Health benefits of Silybum marianum: phytochemistry, pharmacology, and applications. J Agric Food Chem 68:11644\u201311664. https:\/\/doi.org\/10.1021\/ACS.JAFC.0C04791\/ASSET\/IMAGES\/MEDIUM\/JF0C04791_0007.GIF","journal-title":"J Agric Food Chem"},{"key":"4654_CR165","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/J.PHAREP.2016.06.002","volume":"68","author":"VN Thakare","year":"2016","unstructured":"Thakare VN, Dhakane VD, Patel BM (2016) Potential antidepressant-like activity of silymarin in the acute restraint stress in mice: modulation of corticosterone and oxidative stress response in cerebral cortex and hippocampus. Pharmacol Rep 68:1020\u20131027. https:\/\/doi.org\/10.1016\/J.PHAREP.2016.06.002","journal-title":"Pharmacol Rep"},{"key":"4654_CR166","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1177\/0269881117742666","volume":"32","author":"VN Thakare","year":"2018","unstructured":"Thakare VN, Patil RR, Oswal RJ et al (2018) Therapeutic potential of silymarin in chronic unpredictable mild stress induced depressive-like behavior in mice. J Psychopharmacol 32:223\u2013235. https:\/\/doi.org\/10.1177\/0269881117742666","journal-title":"J Psychopharmacol"},{"key":"4654_CR167","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.physbeh.2017.07.010","volume":"179","author":"VN Thakare","year":"2017","unstructured":"Thakare VN, Aswar MK, Kulkarni YP et al (2017) Silymarin ameliorates experimentally induced depressive like behavior in rats: involvement of hippocampal BDNF signaling, inflammatory cytokines and oxidative stress response. Physiol Behav 179:401\u2013410. https:\/\/doi.org\/10.1016\/j.physbeh.2017.07.010","journal-title":"Physiol Behav"},{"key":"4654_CR168","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.bbr.2018.04.025","volume":"348","author":"YJ Li","year":"2018","unstructured":"Li YJ, Li YJ, Di YL et al (2018) Silibinin exerts antidepressant effects by improving neurogenesis through BDNF\/TrkB pathway. Behav Brain Res 348:184\u2013191. https:\/\/doi.org\/10.1016\/j.bbr.2018.04.025","journal-title":"Behav Brain Res"},{"key":"4654_CR169","doi-asserted-by":"publisher","unstructured":"Bao AM, Ruh\u00e9 HG, Gao SF, Swaab DF (2012) Neurotransmitters and neuropeptides in depression. Handb Clin Neurol 106:107\u2013136. https:\/\/doi.org\/10.1016\/B978-0-444-52002-9.00008-5","DOI":"10.1016\/B978-0-444-52002-9.00008-5"},{"key":"4654_CR170","unstructured":"Nutt DJ (2008) Relationship of neurotransmitters to the symptoms of major depressive disorder. J Clin Psychiatry 69:4\u20137"},{"key":"4654_CR171","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3109\/13880209.2014.942787","volume":"53","author":"M Khoshnoodi","year":"2015","unstructured":"Khoshnoodi M, Fakhraei N, Dehpour AR (2015) Possible involvement of nitric oxide in antidepressant-like effect of silymarin in male mice. Pharm Biol 53:739\u2013745. https:\/\/doi.org\/10.3109\/13880209.2014.942787","journal-title":"Pharm Biol"},{"key":"4654_CR172","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1055\/A-0710-5673","volume":"85","author":"T El-Elimat","year":"2019","unstructured":"El-Elimat T, Alzoubi KH, Abualsamen MM et al (2019) Silymarin prevents memory impairments, anxiety, and depressive-like symptoms in a rat model of post-traumatic stress disorder. Planta Med 85:32\u201340. https:\/\/doi.org\/10.1055\/A-0710-5673","journal-title":"Planta Med"},{"key":"4654_CR173","doi-asserted-by":"publisher","first-page":"968","DOI":"10.22038\/IJBMS.2019.34284.8147","volume":"22","author":"V Akbari-Kordkheyli","year":"2019","unstructured":"Akbari-Kordkheyli V, Abbaszadeh-Goudarzi K, Nejati-Laskokalayeh M et al (2019) The protective effects of silymarin on ischemia-reperfusion injuries: a mechanistic review. Iran J Basic Med Sci 22:968\u2013976. https:\/\/doi.org\/10.22038\/IJBMS.2019.34284.8147","journal-title":"Iran J Basic Med Sci"},{"key":"4654_CR174","doi-asserted-by":"publisher","unstructured":"Muley MM, Thakare VN, Patil RR, et al (2013) Amelioration of cognitive, motor and endogenous defense functions with silymarin, piracetam and protocatechuic acid in the cerebral global ischemic rat model. Life Sci 93:51\u201357. https:\/\/doi.org\/10.1016\/j.lfs.2013.05.020","DOI":"10.1016\/j.lfs.2013.05.020"},{"key":"4654_CR175","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1111\/J.1471-4159.1992.TB10990.X","volume":"59","author":"B Halliwell","year":"1992","unstructured":"Halliwell B (1992) Reactive oxygen species and the central nervous system. J Neurochem 59:1609\u20131623. https:\/\/doi.org\/10.1111\/J.1471-4159.1992.TB10990.X","journal-title":"J Neurochem"},{"key":"4654_CR176","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jns.2010.12.006","volume":"302","author":"KY Yoo","year":"2011","unstructured":"Yoo KY, Lee CH, Park JH et al (2011) Antioxidant enzymes are differently changed in experimental ischemic hippocampal CA1 region following repeated restraint stress. J Neurol Sci 302:33\u201342. https:\/\/doi.org\/10.1016\/j.jns.2010.12.006","journal-title":"J Neurol Sci"},{"key":"4654_CR177","unstructured":"Karabag H, Ko\u00e7arslan S (2020) Comparison of the effects of thymoquinone and silymarin on the brain of rats having ischemia-reperfusion in the lower extremities. Ann Ital Chir 91:131\u2013136"},{"key":"4654_CR178","doi-asserted-by":"publisher","first-page":"10","DOI":"10.5897\/JNBH2014.0120","volume":"9","author":"C Shivani","year":"2017","unstructured":"Shivani C, Lubhan S, Kedarinath T, Vipul K (2017) Neuroprotective effect of Silibinin against middle cerebral artery occlusion induced focal cerebral ischemia and brain injury in Wistar rats. J Neurosci Behav Heal 9:10\u201315. https:\/\/doi.org\/10.5897\/JNBH2014.0120","journal-title":"J Neurosci Behav Heal"},{"key":"4654_CR179","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/J.NEULET.2012.08.078","volume":"529","author":"C Wang","year":"2012","unstructured":"Wang C, Wang Z, Zhang X et al (2012) Protection by silibinin against experimental ischemic stroke: up-regulated pAkt, pmTOR, HIF-1\u03b1 and Bcl-2, down-regulated Bax, NF-\u03baB expression. Neurosci Lett 529:45\u201350. https:\/\/doi.org\/10.1016\/J.NEULET.2012.08.078","journal-title":"Neurosci Lett"},{"key":"4654_CR180","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1161\/01.STR.0000200561.69611.f8","volume":"37","author":"\u00c1 Chamorro","year":"2006","unstructured":"Chamorro \u00c1, Hallenbeck J (2006) The harms and benefits of inflammatory and immune responses in vascular disease. Stroke 37:291\u2013293. https:\/\/doi.org\/10.1161\/01.STR.0000200561.69611.f8","journal-title":"Stroke"},{"key":"4654_CR181","doi-asserted-by":"publisher","unstructured":"Hou Y, Liou K, Chern C (2010) Preventive effect of silymarin in cerebral ischemia\u2013reperfusion-induced brain injury in rats possibly through impairing NF-\u03baB and STAT-1 activation. Phytomedicine 17:963\u2013973. https:\/\/doi.org\/10.1016\/j.phymed.2010.03.012","DOI":"10.1016\/j.phymed.2010.03.012"},{"key":"4654_CR182","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/J.BRAINRES.2016.06.018","volume":"1646","author":"K Hirayama","year":"2016","unstructured":"Hirayama K, Oshima H, Yamashita A et al (2016) Neuroprotective effects of silymarin on ischemia-induced delayed neuronal cell death in rat hippocampus. Brain Res 1646:297\u2013303. https:\/\/doi.org\/10.1016\/J.BRAINRES.2016.06.018","journal-title":"Brain Res"},{"key":"4654_CR183","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/J.JNS.2011.07.035","volume":"309","author":"SS Raza","year":"2011","unstructured":"Raza SS, Khan MM, Ashafaq M et al (2011) Silymarin protects neurons from oxidative stress associated damages in focal cerebral ischemia: a behavioral, biochemical and immunohistological study in Wistar rats. J Neurol Sci 309:45\u201354. https:\/\/doi.org\/10.1016\/J.JNS.2011.07.035","journal-title":"J Neurol Sci"},{"key":"4654_CR184","doi-asserted-by":"publisher","unstructured":"Wyant KJ, Ridder AJ, Dayalu P (2017) Huntington\u2019s disease-update on treatments. Curr Neurol Neurosci Rep 17:. https:\/\/doi.org\/10.1007\/S11910-017-0739-9","DOI":"10.1007\/S11910-017-0739-9"},{"key":"4654_CR185","doi-asserted-by":"publisher","first-page":"100130","DOI":"10.1016\/j.crphar.2022.100130","volume":"3","author":"P Chandolia","year":"2022","unstructured":"Chandolia P, Rahi V, Kumar P (2022) Neuroprotective effect of silymarin against 3-nitropropionic acid-induced neurotoxicity in rats. Curr Res Pharmacol Drug Discov 3:100130. https:\/\/doi.org\/10.1016\/j.crphar.2022.100130","journal-title":"Curr Res Pharmacol Drug Discov"},{"key":"4654_CR186","doi-asserted-by":"publisher","first-page":"363","DOI":"10.5530\/IJPI.2022.3.61","volume":"12","author":"AA Bhimanwar","year":"2022","unstructured":"Bhimanwar AA, Ghaisas MM, Shete RV (2022) Silymarin, quercetin and hesperidin combination ameliorates learning and memory deficit in 3 nitro propionic acid induced rat model of Huntington\u2019s disease. Int J Pharm Investig 12:363\u2013369. https:\/\/doi.org\/10.5530\/IJPI.2022.3.61","journal-title":"Int J Pharm Investig"},{"key":"4654_CR187","doi-asserted-by":"publisher","unstructured":"Shokouhi G, Kosari-Nasab M, Salari AA (2020) Silymarin sex-dependently improves cognitive functions and alters TNF-\u03b1, BDNF, and glutamate in the hippocampus of mice with mild traumatic brain injury. Life Sci 257:. https:\/\/doi.org\/10.1016\/J.LFS.2020.118049","DOI":"10.1016\/J.LFS.2020.118049"},{"key":"4654_CR188","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.taap.2017.11.012","volume":"338","author":"M Kosari-Nasab","year":"2018","unstructured":"Kosari-Nasab M, Shokouhi G, Ghorbanihaghjo A et al (2018) Anxiolytic- and antidepressant-like effects of Silymarin compared to diazepam and fluoxetine in a mouse model of mild traumatic brain injury. Toxicol Appl Pharmacol 338:159\u2013173. https:\/\/doi.org\/10.1016\/j.taap.2017.11.012","journal-title":"Toxicol Appl Pharmacol"},{"key":"4654_CR189","doi-asserted-by":"publisher","first-page":"266","DOI":"10.5607\/en.2017.26.5.266","volume":"26","author":"S Kim","year":"2017","unstructured":"Kim S, Jung UJ, Oh YS et al (2017) Beneficial effects of silibinin against kainic acidinduced neurotoxicity in the hippocampus in vivo. Exp Neurobiol 26:266\u2013277. https:\/\/doi.org\/10.5607\/en.2017.26.5.266","journal-title":"Exp Neurobiol"},{"key":"4654_CR190","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3329\/bjp.v11i3.26181","volume":"11","author":"U Waqar","year":"2016","unstructured":"Waqar U, Khan HM, Anjum AA (2016) Antiepileptic potential of Silybum marianum seeds in pentylenetetrazol-induced kindled mice. Bangladesh J Pharmacol 11:306\u2013309","journal-title":"Bangladesh J Pharmacol"},{"key":"4654_CR191","first-page":"45","volume":"45","author":"R Sedaghat","year":"2016","unstructured":"Sedaghat R, Zarrinkhameh Z, Afshin-Majd S et al (2016) The effect of silymarin on prevention of hippocampus neuronal damage in rats with temporal lob epilepsy. J Basic Clin Pathophysiol 45:45\u201350","journal-title":"J Basic Clin Pathophysiol"},{"key":"4654_CR192","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/jnr.23544","volume":"93","author":"Y Lee","year":"2015","unstructured":"Lee Y, Park HR, Chun HJ, Lee J (2015) Silibinin prevents dopaminergic neuronal loss in a mouse model of Parkinson\u2019s disease via mitochondrial stabilization. J Neurosci Res 93:755\u2013765. https:\/\/doi.org\/10.1002\/jnr.23544","journal-title":"J Neurosci Res"},{"key":"4654_CR193","doi-asserted-by":"publisher","first-page":"123","DOI":"10.47176\/mjiri.37.123","volume":"37","author":"A Rustamzadeh","year":"2023","unstructured":"Rustamzadeh A, Sadigh N, Shabani R et al (2023) Neurochemical ameliorating of the hippocampus in dyslipidemic Alzheimer patients following silymarin; a double-blind placebo-controlled randomized clinical trial. Med J Islam Repub Iran 37:123. https:\/\/doi.org\/10.47176\/mjiri.37.123","journal-title":"Med J Islam Repub Iran"},{"key":"4654_CR194","doi-asserted-by":"publisher","first-page":"83","DOI":"10.13005\/bpj\/2345","volume":"15","author":"SA Hussain","year":"2022","unstructured":"Hussain SA, Abdulrahman ZS, Mustafa WW (2022) Silibinin improves the clinical scores of memory function in patients with mild cognitive impairment: a double-blind, placebo-controlled pilot study. Biomed Pharmacol J 15:83\u201390. https:\/\/doi.org\/10.13005\/bpj\/2345","journal-title":"Biomed Pharmacol J"},{"key":"4654_CR195","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/1028415X.2023.2301163","volume":"14","author":"SM Navabi","year":"2024","unstructured":"Navabi SM, Elieh-Ali-Komi D, Afshari D et al (2024) Adjunctive silymarin supplementation and its effects on disease severity, oxidative stress, and inflammation in patients with Alzheimer\u2019s disease. Nutr Neurosci 14:1\u201311. https:\/\/doi.org\/10.1080\/1028415X.2023.2301163","journal-title":"Nutr Neurosci"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04654-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-024-04654-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04654-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T03:45:49Z","timestamp":1747194349000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-024-04654-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,17]]},"references-count":195,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["4654"],"URL":"https:\/\/doi.org\/10.1007\/s12035-024-04654-y","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,17]]},"assertion":[{"value":"13 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}